Literature DB >> 9700190

Linkage and association of adrenergic and dopamine receptor genes in the distal portion of the long arm of chromosome 5 with systolic blood pressure variation.

J Krushkal1, M Xiong, R Ferrell, C F Sing, S T Turner, E Boerwinkle.   

Abstract

Elevated blood pressure is an important risk factor for renal-, cerebro- and cardiovascular diseases. We used an efficient discordant sib-pair ascertainment scheme to investigate the impact of the distal end of the long arm of human chromosome 5 (chromosomal region 5q31.1-qter) containing genes for the alpha1B and beta2 adrenergic receptors and the dopamine receptor type 1A on variation of systolic blood pressure in young Caucasians. We measured eight highly polymorphic markers spanning this positional candidate gene-rich region in 427 individuals from 55 three-generation pedigrees containing 69 discordant sibling pairs, and calculated multipoint identity by descent (MIBD) probabilities. The results of genetic linkage and association tests indicate that the region between markers D5S2093 and D5S462 is significantly linked to one or more polymorphic genes influencing interindividual variation in systolic blood pressure levels. Since the alpha1B adrenergic receptor and dopamine receptor type 1A genes are located close to these markers, these data suggest that genetic variation in one or both of these G protein-coupled receptors, which participate in the control of vascular tone, plays an important role in influencing interindividual variation in systolic blood pressure levels.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9700190     DOI: 10.1093/hmg/7.9.1379

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  25 in total

Review 1.  Context-dependent genetic effects in hypertension.

Authors:  S L Kardia
Journal:  Curr Hypertens Rep       Date:  2000-02       Impact factor: 5.369

Review 2.  Genetic rat models of hypertension: relationship to human hypertension.

Authors:  M Stoll; H J Jacob
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

Review 3.  Drugs for the perioperative control of hypertension: current issues and future directions.

Authors:  Robert Feneck
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 4.  Genetic architecture of complex traits predisposing to nephropathy: hypertension.

Authors:  Steven C Hunt
Journal:  Semin Nephrol       Date:  2010-03       Impact factor: 5.299

5.  New target regions for human hypertension via comparative genomics.

Authors:  M Stoll; A E Kwitek-Black; A W Cowley; E L Harris; S B Harrap; J E Krieger; M P Printz; A P Provoost; J Sassard; H J Jacob
Journal:  Genome Res       Date:  2000-04       Impact factor: 9.043

Review 6.  Linkage mapping for hypertension susceptibility genes.

Authors:  N Kato; C Julier
Journal:  Curr Hypertens Rep       Date:  1999 Feb-Mar       Impact factor: 5.369

Review 7.  The role of beta(2)-adrenergic receptor variation in human hypertension.

Authors:  M S Bray; E Boerwinkle
Journal:  Curr Hypertens Rep       Date:  2000-02       Impact factor: 5.369

8.  A new essential hypertension susceptibility locus on chromosome 2p24-p25, detected by genomewide search.

Authors:  Andrea Angius; Enrico Petretto; Giovanni Battista Maestrale; Paola Forabosco; Giuseppina Casu; Daniela Piras; Manuela Fanciulli; Mario Falchi; Paola Maria Melis; Mario Palermo; Mario Pirastu
Journal:  Am J Hum Genet       Date:  2002-09-12       Impact factor: 11.025

Review 9.  Dopamine, kidney, and hypertension: studies in dopamine receptor knockout mice.

Authors:  Xiaoyan Wang; Van Anthony M Villar; Ines Armando; Gilbert M Eisner; Robin A Felder; Pedro A Jose
Journal:  Pediatr Nephrol       Date:  2008-07-10       Impact factor: 3.714

Review 10.  Identifying genes for coronary artery disease: An idea whose time has come.

Authors:  Robert Roberts; Alexandre F R Stewart; George A Wells; Kathryn A Williams; Nihan Kavaslar; Ruth McPherson
Journal:  Can J Cardiol       Date:  2007-08       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.